Cargando…
A Comparative Analysis of Photon versus Proton Beam Therapy in Neoadjuvant Concurrent Chemoradiotherapy for Intrathoracic Squamous Cell Carcinoma of the Esophagus at a Single Institute
SIMPLE SUMMARY: Radiotherapy for an esophageal malignancy results in undesired radiation exposure to nearby critical organs such as the heart, lungs, and spinal cord, leading to unfavorable clinical outcomes. Although only utilized at a few centers, proton beam radiotherapy spares adjacent organs fr...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031285/ https://www.ncbi.nlm.nih.gov/pubmed/35454939 http://dx.doi.org/10.3390/cancers14082033 |
_version_ | 1784692352893321216 |
---|---|
author | Choi, Jin-Ho Lee, Jong Mog Kim, Moon Soo Lee, Youngjoo Suh, Yang-Gun Lee, Sung Uk Lee, Doo Yeul Oh, Eun Sang Kim, Tae hyun Moon, Sung Ho |
author_facet | Choi, Jin-Ho Lee, Jong Mog Kim, Moon Soo Lee, Youngjoo Suh, Yang-Gun Lee, Sung Uk Lee, Doo Yeul Oh, Eun Sang Kim, Tae hyun Moon, Sung Ho |
author_sort | Choi, Jin-Ho |
collection | PubMed |
description | SIMPLE SUMMARY: Radiotherapy for an esophageal malignancy results in undesired radiation exposure to nearby critical organs such as the heart, lungs, and spinal cord, leading to unfavorable clinical outcomes. Although only utilized at a few centers, proton beam radiotherapy spares adjacent organs from radiation exposure more effectively than conventional photon radiotherapy. We confirmed that, in terms of sparing adjacent organs from radiation, proton beam radiotherapy, as a modality of neoadjuvant chemoradiotherapy, was significantly superior to conventional photon radiotherapy for locally advanced esophageal squamous cell carcinoma with an even distribution of intrathoracic locations, and may lead to improved clinical outcomes. ABSTRACT: Background: Proton beam therapy (PBT), as a neoadjuvant chemoradiotherapy (nCRT) modality, is expected to result in better outcomes than photon-based radiotherapy (RT) for esophageal cancer, particularly adenocarcinoma. This study reports the results of nCRT for locally advanced esophageal squamous cell carcinoma (ESCC) using both modalities. Methods: We retrospectively reviewed the records of patients who underwent nCRT for ESCC between 2001 and 2020. A median of 41.4 Gy or cobalt gray equivalents of radiation was delivered using either photons or protons, with concurrent chemotherapy. Dosimetric and clinical parameters were compared between the two groups. Results: Of the 31 patients, the lungs and heart of the proton group (n = 15) were exposed to significantly less radiation compared to the photon group (n = 16). No significant differences in short-term postoperative outcomes or lymphocyte count were observed between the groups, and there were no significant differences between the photon and proton groups in 2-year overall survival (67.8% vs. 68.6%, p = 0.867) or 2-year disease-free survival (33.3% vs. 34.5%, p = 0.749), with a median follow-up of 17 months. Conclusions: PBT provided a significant dosimetric benefit over photon-based RT during nCRT for ESCC; however, it did not improve clinical outcomes. |
format | Online Article Text |
id | pubmed-9031285 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90312852022-04-23 A Comparative Analysis of Photon versus Proton Beam Therapy in Neoadjuvant Concurrent Chemoradiotherapy for Intrathoracic Squamous Cell Carcinoma of the Esophagus at a Single Institute Choi, Jin-Ho Lee, Jong Mog Kim, Moon Soo Lee, Youngjoo Suh, Yang-Gun Lee, Sung Uk Lee, Doo Yeul Oh, Eun Sang Kim, Tae hyun Moon, Sung Ho Cancers (Basel) Article SIMPLE SUMMARY: Radiotherapy for an esophageal malignancy results in undesired radiation exposure to nearby critical organs such as the heart, lungs, and spinal cord, leading to unfavorable clinical outcomes. Although only utilized at a few centers, proton beam radiotherapy spares adjacent organs from radiation exposure more effectively than conventional photon radiotherapy. We confirmed that, in terms of sparing adjacent organs from radiation, proton beam radiotherapy, as a modality of neoadjuvant chemoradiotherapy, was significantly superior to conventional photon radiotherapy for locally advanced esophageal squamous cell carcinoma with an even distribution of intrathoracic locations, and may lead to improved clinical outcomes. ABSTRACT: Background: Proton beam therapy (PBT), as a neoadjuvant chemoradiotherapy (nCRT) modality, is expected to result in better outcomes than photon-based radiotherapy (RT) for esophageal cancer, particularly adenocarcinoma. This study reports the results of nCRT for locally advanced esophageal squamous cell carcinoma (ESCC) using both modalities. Methods: We retrospectively reviewed the records of patients who underwent nCRT for ESCC between 2001 and 2020. A median of 41.4 Gy or cobalt gray equivalents of radiation was delivered using either photons or protons, with concurrent chemotherapy. Dosimetric and clinical parameters were compared between the two groups. Results: Of the 31 patients, the lungs and heart of the proton group (n = 15) were exposed to significantly less radiation compared to the photon group (n = 16). No significant differences in short-term postoperative outcomes or lymphocyte count were observed between the groups, and there were no significant differences between the photon and proton groups in 2-year overall survival (67.8% vs. 68.6%, p = 0.867) or 2-year disease-free survival (33.3% vs. 34.5%, p = 0.749), with a median follow-up of 17 months. Conclusions: PBT provided a significant dosimetric benefit over photon-based RT during nCRT for ESCC; however, it did not improve clinical outcomes. MDPI 2022-04-18 /pmc/articles/PMC9031285/ /pubmed/35454939 http://dx.doi.org/10.3390/cancers14082033 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Choi, Jin-Ho Lee, Jong Mog Kim, Moon Soo Lee, Youngjoo Suh, Yang-Gun Lee, Sung Uk Lee, Doo Yeul Oh, Eun Sang Kim, Tae hyun Moon, Sung Ho A Comparative Analysis of Photon versus Proton Beam Therapy in Neoadjuvant Concurrent Chemoradiotherapy for Intrathoracic Squamous Cell Carcinoma of the Esophagus at a Single Institute |
title | A Comparative Analysis of Photon versus Proton Beam Therapy in Neoadjuvant Concurrent Chemoradiotherapy for Intrathoracic Squamous Cell Carcinoma of the Esophagus at a Single Institute |
title_full | A Comparative Analysis of Photon versus Proton Beam Therapy in Neoadjuvant Concurrent Chemoradiotherapy for Intrathoracic Squamous Cell Carcinoma of the Esophagus at a Single Institute |
title_fullStr | A Comparative Analysis of Photon versus Proton Beam Therapy in Neoadjuvant Concurrent Chemoradiotherapy for Intrathoracic Squamous Cell Carcinoma of the Esophagus at a Single Institute |
title_full_unstemmed | A Comparative Analysis of Photon versus Proton Beam Therapy in Neoadjuvant Concurrent Chemoradiotherapy for Intrathoracic Squamous Cell Carcinoma of the Esophagus at a Single Institute |
title_short | A Comparative Analysis of Photon versus Proton Beam Therapy in Neoadjuvant Concurrent Chemoradiotherapy for Intrathoracic Squamous Cell Carcinoma of the Esophagus at a Single Institute |
title_sort | comparative analysis of photon versus proton beam therapy in neoadjuvant concurrent chemoradiotherapy for intrathoracic squamous cell carcinoma of the esophagus at a single institute |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031285/ https://www.ncbi.nlm.nih.gov/pubmed/35454939 http://dx.doi.org/10.3390/cancers14082033 |
work_keys_str_mv | AT choijinho acomparativeanalysisofphotonversusprotonbeamtherapyinneoadjuvantconcurrentchemoradiotherapyforintrathoracicsquamouscellcarcinomaoftheesophagusatasingleinstitute AT leejongmog acomparativeanalysisofphotonversusprotonbeamtherapyinneoadjuvantconcurrentchemoradiotherapyforintrathoracicsquamouscellcarcinomaoftheesophagusatasingleinstitute AT kimmoonsoo acomparativeanalysisofphotonversusprotonbeamtherapyinneoadjuvantconcurrentchemoradiotherapyforintrathoracicsquamouscellcarcinomaoftheesophagusatasingleinstitute AT leeyoungjoo acomparativeanalysisofphotonversusprotonbeamtherapyinneoadjuvantconcurrentchemoradiotherapyforintrathoracicsquamouscellcarcinomaoftheesophagusatasingleinstitute AT suhyanggun acomparativeanalysisofphotonversusprotonbeamtherapyinneoadjuvantconcurrentchemoradiotherapyforintrathoracicsquamouscellcarcinomaoftheesophagusatasingleinstitute AT leesunguk acomparativeanalysisofphotonversusprotonbeamtherapyinneoadjuvantconcurrentchemoradiotherapyforintrathoracicsquamouscellcarcinomaoftheesophagusatasingleinstitute AT leedooyeul acomparativeanalysisofphotonversusprotonbeamtherapyinneoadjuvantconcurrentchemoradiotherapyforintrathoracicsquamouscellcarcinomaoftheesophagusatasingleinstitute AT oheunsang acomparativeanalysisofphotonversusprotonbeamtherapyinneoadjuvantconcurrentchemoradiotherapyforintrathoracicsquamouscellcarcinomaoftheesophagusatasingleinstitute AT kimtaehyun acomparativeanalysisofphotonversusprotonbeamtherapyinneoadjuvantconcurrentchemoradiotherapyforintrathoracicsquamouscellcarcinomaoftheesophagusatasingleinstitute AT moonsungho acomparativeanalysisofphotonversusprotonbeamtherapyinneoadjuvantconcurrentchemoradiotherapyforintrathoracicsquamouscellcarcinomaoftheesophagusatasingleinstitute AT choijinho comparativeanalysisofphotonversusprotonbeamtherapyinneoadjuvantconcurrentchemoradiotherapyforintrathoracicsquamouscellcarcinomaoftheesophagusatasingleinstitute AT leejongmog comparativeanalysisofphotonversusprotonbeamtherapyinneoadjuvantconcurrentchemoradiotherapyforintrathoracicsquamouscellcarcinomaoftheesophagusatasingleinstitute AT kimmoonsoo comparativeanalysisofphotonversusprotonbeamtherapyinneoadjuvantconcurrentchemoradiotherapyforintrathoracicsquamouscellcarcinomaoftheesophagusatasingleinstitute AT leeyoungjoo comparativeanalysisofphotonversusprotonbeamtherapyinneoadjuvantconcurrentchemoradiotherapyforintrathoracicsquamouscellcarcinomaoftheesophagusatasingleinstitute AT suhyanggun comparativeanalysisofphotonversusprotonbeamtherapyinneoadjuvantconcurrentchemoradiotherapyforintrathoracicsquamouscellcarcinomaoftheesophagusatasingleinstitute AT leesunguk comparativeanalysisofphotonversusprotonbeamtherapyinneoadjuvantconcurrentchemoradiotherapyforintrathoracicsquamouscellcarcinomaoftheesophagusatasingleinstitute AT leedooyeul comparativeanalysisofphotonversusprotonbeamtherapyinneoadjuvantconcurrentchemoradiotherapyforintrathoracicsquamouscellcarcinomaoftheesophagusatasingleinstitute AT oheunsang comparativeanalysisofphotonversusprotonbeamtherapyinneoadjuvantconcurrentchemoradiotherapyforintrathoracicsquamouscellcarcinomaoftheesophagusatasingleinstitute AT kimtaehyun comparativeanalysisofphotonversusprotonbeamtherapyinneoadjuvantconcurrentchemoradiotherapyforintrathoracicsquamouscellcarcinomaoftheesophagusatasingleinstitute AT moonsungho comparativeanalysisofphotonversusprotonbeamtherapyinneoadjuvantconcurrentchemoradiotherapyforintrathoracicsquamouscellcarcinomaoftheesophagusatasingleinstitute |